PROM1 and glioblastoma: Flow cytometry detection showed that in the CD133+ glioblastoma cell-induced tumors, there was a significantly higher percentage of CD133+ cells (2.47±0.67% of the total cells) compared with the CD133− glioblastoma cell-induced tumors (0.44±0.14% of total cells; P<0.05).